Oral Consequences of Systemic Lupus Erythematosus: an Update

被引:0
|
作者
Gegout P.-Y. [1 ,2 ]
Wabbi R. [1 ,2 ]
Jung S. [1 ,2 ,3 ]
Huck O. [1 ,2 ]
机构
[1] Faculté de Chirurgie Dentaire, Université de Strasbourg, 8 Rue Sainte-Elisabeth, Strasbourg
[2] Pôle de Médecine Et Chirurgie Bucco-Dentaires, Hôpitaux Universitaires de Strasbourg, Strasbourg
[3] Centre de Référence Des Maladies Rares Orales Et Dentaires (O-Rares), Faculté de Chirurgie Dentaire, Université de Strasbourg, Strasbourg
关键词
Autoimmune; Implant; Oral management; Orofacial manifestations; Periodontitis; Systemic lupus erythematosus;
D O I
10.1007/s40496-023-00356-x
中图分类号
学科分类号
摘要
Purpose of Review: Systemic lupus erythematosus (SLE) is an autoimmune disease affecting multiple organs that has been associated with various oral manifestations. It affects mainly adult women, and its incidence is estimated to be 5.14 per 100,000 persons/year. Oral manifestations such as mucosal, periodontal, or carious lesions are common in SLE as well as temporomandibular joint disorders. Recent Findings: This systematic review aims to identify the oral manifestations of SLE and to evaluate the at-distance impact of SLE on oral health as well as to give clinical guidance for the oral care of SLE patients. Summary: SLE has a negative impact on general and oral health. The mechanisms underlying the development and progression of the disease are still not fully understood; however, genetic predispositions, environmental factors, or hormones might be involved in the onset of SLE. SLE treatment aims to control and limit the disease progression and expression by the adjunctive use of corticoids or immunosuppressive drugs that can impact oral health and management. © 2023, The Author(s), under exclusive licence to Springer Nature Switzerland AG.
引用
收藏
页码:184 / 195
页数:11
相关论文
共 50 条
  • [31] Update on complement in the pathogenesis of systemic lupus erythematosus
    Molina, H
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2002, 14 (05) : 492 - 497
  • [32] Belimumab in systemic lupus erythematosus: an update for clinicians
    Kim, Susan S.
    Kirou, Kyriakos A.
    Erkan, Doruk
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2012, 3 (01) : 11 - 23
  • [33] Malignancies in systemic lupus erythematosus: a 2015 update
    Goobie, Gillian C.
    Bernatsky, Sasha
    Ramsey-Goldman, Rosalind
    Clarke, Ann E.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2015, 27 (05) : 454 - 460
  • [34] Update on belimumab for the management of systemic lupus erythematosus
    Lutalo, Pamela M. K.
    D'Cruz, David P.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (11) : 1701 - 1708
  • [35] Treatment of Systemic Lupus Erythematosus A 2012 Update
    Merrill, Joan T.
    [J]. BULLETIN OF THE HOSPITAL FOR JOINT DISEASES, 2012, 70 (03): : 172 - 176
  • [36] Update on clinical trials in systemic lupus erythematosus
    Narain, Sonali
    Furie, Richard
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2016, 28 (05) : 469 - 479
  • [37] Update on Biologic Therapies for Systemic Lupus Erythematosus
    Helena Hiemisch Lobo Borba
    Andreas Funke
    Astrid Wiens
    Shirley Ramos da Rosa Utiyama
    Cássio Marques Perlin
    Roberto Pontarolo
    [J]. Current Rheumatology Reports, 2016, 18
  • [38] Vitamin D and systemic lupus erythematosus: an update
    Mok, Chi Chiu
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (05) : 453 - 463
  • [39] Genetic advances in systemic lupus erythematosus: an update
    Chen, Lingyan
    Morris, David L.
    Vyse, Timothy J.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2017, 29 (05) : 423 - 433
  • [40] A Contemporary Update on the Diagnosis of Systemic Lupus Erythematosus
    Xin Huang
    Qing Zhang
    Huilin Zhang
    Qianjin Lu
    [J]. Clinical Reviews in Allergy & Immunology, 2022, 63 : 311 - 329